Big Data Analytics for Medication Management in Diabetes Mellitus

Lidong Wang, Cheryl Ann Alexander


Medication development plays a prominent role in the fight against chronic illness such as hypertension, diabetes mellitus, asthma, etc. Without proper testing and methods for management of drug data, the disease management would fail. Providers rely on pharmaceutical companies to provide research data in widespread formats and pharmaceutical companies rely on hospitals for electronic medical record data (EHR) and for pharmacy refill records from insurance companies. Big Data Analytics (BDA) provides an excellent basis to examine and manage terabytes of data that comprises drug data and can manage all aspects of drug development. This survey paper examines the current literature to determine what is current practice in the area of Big Data analytics and medication management.

Full Text:




  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

International Journal of Studies in Nursing  ISSN 2424-9653 (Print)  ISSN 2529-7317 (Online)

Copyright © July Press

To make sure that you can receive messages from us, please add the '' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.